Header Logo

Connection

Philip Liebson to Angiotensin II Type 1 Receptor Blockers

Back to Details
This is a "connection" page, showing publications Philip Liebson has written about Angiotensin II Type 1 Receptor Blockers.
Philip Liebson
Connection Strength
0.230
Angiotensin II Type 1 Receptor Blockers
  1. Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET): implications for reduced cardiovascular risk. Prev Cardiol. 2009; 12(1):43-50.
    View in: PubMed
    Score: 0.082
  2. ENHANCE and ONTARGET. Prev Cardiol. 2008; 11(3):179-82.
    View in: PubMed
    Score: 0.077
  3. Calcium channel blockers in the spectrum of antihypertensive agents. Expert Opin Pharmacother. 2006 Dec; 7(17):2385-401.
    View in: PubMed
    Score: 0.071
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.